Olaregen needs to get the product in the hands of
Post# of 36537
(Total Views: 200)
Posted On: 10/19/2019 10:44:21 AM
Re: Paul Jackson #7503
Olaregen needs to get the product in the hands of wound care and other docs.
I know they contracted with AvKare for the VA line of business. This makes sense as there is large population of patients and it is relatively easy to get the reps> docs educated and distributing the product to a system already familiar with AvKare.
Private practice docs throughout the country is a whole other deal. I assume the Oct 1 launch announcement of the product means it will be implemented as funds allow.
Can we accomplish this as an OTC stock?
I know they contracted with AvKare for the VA line of business. This makes sense as there is large population of patients and it is relatively easy to get the reps> docs educated and distributing the product to a system already familiar with AvKare.
Private practice docs throughout the country is a whole other deal. I assume the Oct 1 launch announcement of the product means it will be implemented as funds allow.
Can we accomplish this as an OTC stock?
(1)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼